This analysis examines the historical and forecast performance for Menarini in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.

Scope

Highlights

Reasons to Purchase

Benchmark Menarini's performance against key rivals in the ethical pharmaceutical sector Analyze how Menarini will continue to utilize in-licensing opportunities to drive sales growth out to 2011 Determine whether the company will develop its in-house R&D capabilities in order to reduce long-term in-licensing dependence